Please provide your email address to receive an email when new articles are posted on . This study reports results from a prospective, randomized, double-blind trial. Use of IV tranexamic acid did not ...
Whether prehospital administration of tranexamic acid increases the likelihood of survival with a favorable functional outcome among patients with major trauma and suspected trauma-induced ...
The use of tranexamic acid (TXA) in patients undergoing oncology and other major noncardiac surgeries reduces the administration of red blood cell (RBC) transfusions across patient and surgical ...
Tranexamic acid (TXA) use is set to widen in England and Wales under new draft guidance from the National Institute for Health and Care Excellence (NICE). NICE recommends offering TXA before any ...
Please provide your email address to receive an email when new articles are posted on . Tranexamic acid lowered the need for transfusions for patients undergoing non-cardiac surgeries compared with ...
Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically rather than intravenously did not meet its primary endpoint of reducing seizures and was stopped ...
The FDA is requiring stronger warnings for tranexamic acid (TXA) injection to avoid medication errors following reports of serious injury, including death. "FDA is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results